Cargando…

A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial

PURPOSE: The objective of this study was to evaluate the effect of an intervention (Growing Resilience And CouragE; GRACE) on spiritual well-being, quality of life, and general well-being in women with metastatic cancers reporting existential or spiritual distress. PATIENTS AND METHODS: Prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales: Asher, Arash, Shirazipour, Celina H, Capaldi, Jessica M, Kim, Sungjin, Diniz, Marcio, Jones, Bronwen, Wertheimer, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400157/
https://www.ncbi.nlm.nih.gov/pubmed/37104871
http://dx.doi.org/10.1093/oncolo/oyad091
_version_ 1785084404067991552
author Asher, Arash
Shirazipour, Celina H
Capaldi, Jessica M
Kim, Sungjin
Diniz, Marcio
Jones, Bronwen
Wertheimer, Jeffrey
author_facet Asher, Arash
Shirazipour, Celina H
Capaldi, Jessica M
Kim, Sungjin
Diniz, Marcio
Jones, Bronwen
Wertheimer, Jeffrey
author_sort Asher, Arash
collection PubMed
description PURPOSE: The objective of this study was to evaluate the effect of an intervention (Growing Resilience And CouragE; GRACE) on spiritual well-being, quality of life, and general well-being in women with metastatic cancers reporting existential or spiritual distress. PATIENTS AND METHODS: Prospective, randomized, wait-list control clinical trial. Women with metastatic cancer experiencing existential or spiritual concerns were randomized to GRACE or waitlist control. Survey data were collected at baseline, end of program, and 1-month follow-up. Participants included English-speaking women, 18 or older, with metastatic cancer, existential or spiritual concerns, and reasonable medical stability. Eighty-one women were assessed for eligibility; 10 were excluded (not meeting exclusion criteria, refusal to participate, and death). The primary outcome was spiritual well-being measured pre- and post-program. Secondary measures assessed quality of life, anxiety, depression, hopelessness, and loneliness. RESULTS: Seventy-one women (aged 47-72) were enrolled (GRACE n = 37, waitlist control n = 34). GRACE participants demonstrated significant improvements in spiritual well-being compared to control at end of program (parameter estimate (PE), 16.67, 95% CI, 13.17, 20.16) and 1-month follow-up (PE, 10.31, 95% CI, 6.73, 13.89). Additionally, significant improvements were demonstrated in quality of life at the end of program (PE, 8.51, 95% CI, 4.26, 12.76) and 1-month follow-up (PE, 6.17, 95% CI, 1.75, 10.58). GRACE participants also demonstrated improved depression and hopelessness at follow-up, as well as improved anxiety. CONCLUSIONS: Findings suggest the value of evidence-based psychoeducational and experiential interventions for improving the well-being and quality of life of women with advanced cancer. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02707510.
format Online
Article
Text
id pubmed-10400157
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104001572023-08-04 A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial Asher, Arash Shirazipour, Celina H Capaldi, Jessica M Kim, Sungjin Diniz, Marcio Jones, Bronwen Wertheimer, Jeffrey Oncologist Symptom Management and Supportive Care PURPOSE: The objective of this study was to evaluate the effect of an intervention (Growing Resilience And CouragE; GRACE) on spiritual well-being, quality of life, and general well-being in women with metastatic cancers reporting existential or spiritual distress. PATIENTS AND METHODS: Prospective, randomized, wait-list control clinical trial. Women with metastatic cancer experiencing existential or spiritual concerns were randomized to GRACE or waitlist control. Survey data were collected at baseline, end of program, and 1-month follow-up. Participants included English-speaking women, 18 or older, with metastatic cancer, existential or spiritual concerns, and reasonable medical stability. Eighty-one women were assessed for eligibility; 10 were excluded (not meeting exclusion criteria, refusal to participate, and death). The primary outcome was spiritual well-being measured pre- and post-program. Secondary measures assessed quality of life, anxiety, depression, hopelessness, and loneliness. RESULTS: Seventy-one women (aged 47-72) were enrolled (GRACE n = 37, waitlist control n = 34). GRACE participants demonstrated significant improvements in spiritual well-being compared to control at end of program (parameter estimate (PE), 16.67, 95% CI, 13.17, 20.16) and 1-month follow-up (PE, 10.31, 95% CI, 6.73, 13.89). Additionally, significant improvements were demonstrated in quality of life at the end of program (PE, 8.51, 95% CI, 4.26, 12.76) and 1-month follow-up (PE, 6.17, 95% CI, 1.75, 10.58). GRACE participants also demonstrated improved depression and hopelessness at follow-up, as well as improved anxiety. CONCLUSIONS: Findings suggest the value of evidence-based psychoeducational and experiential interventions for improving the well-being and quality of life of women with advanced cancer. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02707510. Oxford University Press 2023-04-27 /pmc/articles/PMC10400157/ /pubmed/37104871 http://dx.doi.org/10.1093/oncolo/oyad091 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symptom Management and Supportive Care
Asher, Arash
Shirazipour, Celina H
Capaldi, Jessica M
Kim, Sungjin
Diniz, Marcio
Jones, Bronwen
Wertheimer, Jeffrey
A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial
title A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial
title_full A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial
title_fullStr A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial
title_full_unstemmed A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial
title_short A 6-Week Program to Strengthen Resiliency Among Women With Metastatic Cancer: A Randomized Clinical Trial
title_sort 6-week program to strengthen resiliency among women with metastatic cancer: a randomized clinical trial
topic Symptom Management and Supportive Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400157/
https://www.ncbi.nlm.nih.gov/pubmed/37104871
http://dx.doi.org/10.1093/oncolo/oyad091
work_keys_str_mv AT asherarash a6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT shirazipourcelinah a6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT capaldijessicam a6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT kimsungjin a6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT dinizmarcio a6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT jonesbronwen a6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT wertheimerjeffrey a6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT asherarash 6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT shirazipourcelinah 6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT capaldijessicam 6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT kimsungjin 6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT dinizmarcio 6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT jonesbronwen 6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial
AT wertheimerjeffrey 6weekprogramtostrengthenresiliencyamongwomenwithmetastaticcancerarandomizedclinicaltrial